MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number AFAPRO28 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Pericardial Effusion (3271)
|
Event Date 08/01/2022 |
Event Type
Injury
|
Event Description
|
It was reported that during a cryo ablation procedure, a thrombus was observed while the sheath was in the heart.An anticoagulant was administered and there was no longer any evidence of the thrombus.It was also reported that there were difficulties with advancing the sheath across the septum.All four veins were ablated, however post-ablation pacing showed that the right inferior pulmonary vein (ripv) was not isolated.The physician opted to switch to rf.Another manufacturer's radiofrequency catheter was advanced through the medtronic sheath and it was observed that the patient was hypotensive.The radiofrequency catheter was removed and the balloon catheter was inserted back through the sheath.At this point, a significant pericardial effusion and mild tamponade were observed with intracardiac echocardiography (ice).They physician is unsure when the effusion occurred.A pericardiocentesis was performed and a drain was placed which resolved the effusion and patient's hypotension.The case was completed with cryo.It is unknown whether the event caused the patient to have an extended hospitalization.No further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Product event summary: data files were returned and analyzed.Patient files showed at lease 23 applications were performed with balloon catheter afapro28 with lot 16069 on the date of the event.A system notice 50008 the system has detected a software error and stopped the injection was triggered on the beginning of the first application.In conclusion, the clinical issues, (tamponade/ effusion/ hypotension) occurred during the procedure.There is no indication of a relation of the adverse event to the performance or a malfunction of the product.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Product event summary: the balloon catheter afapro28 with lot number 16069 was returned and analyzed.No anomalies were identified during external visual inspection of the balloon, shaft, and handle segments.The catheter smart chip data was downloaded and reviewed.Data indicated the catheter was used for 23 applications on the reported event date.The catheter was recognized and passed the electrical integrity verifications and performance test.The catheter completed the inflation, ablation, and thawing phases with no system notices generated.No performance issues were identified.All pressure and flow were in range and temperature curve had no oscillation or overshoot.In conclusion, the reported clinical issues, tamponade, effusion, and hypotension, occurred during the procedure.There is no indication of a relationship of the adverse event to the performance or a malfunction of the product.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|